Sponsored message
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
Take Two

The complicated ethics of genetic testing for cancer and preemptive surgery

Actress Angelina Jolie speaks ahead of a screening of her new film 'In the Land of Blood and Honey' at the Foreign Commonwealth Office (FCO) on May 29, 2012 in London.
Actress Angelina Jolie recently opened up to the world about her decision to undergo surgery because of a genetic marker that indicated her cancer risk.
(
AFP/AFP/Getty Images
)

Take Two translates the day’s headlines for Southern California, making sense of the news and cultural events that affect our lives. Produced by Southern California Public Radio and broadcast from October 2012 – June 2021. Hosted by A Martinez.

Get LA News Updates Daily

We brief you on what you need to know about L.A. today.
Listen 7:42
The complicated ethics of genetic testing for cancer and preemptive surgery

Last week actress Angelina Jolie made headlines when she revealed that she underwent a voluntary double mastectomy because she found out that she was a carrier of the BRCA1 gene which gave her an 87 percent chance of developing breast cancer.

Now a man in the UK has become the first person to have pre-emptive surgery to remove his prostate because he carried the BRCA2 gene. This was after traditional test had not found evidence of pancreatic cancer.

So what does this say about the future of cancer care? Is there a danger associated with the genetic cancer tests? Will it cause people to request unnecessary surgeries?

Dr. Arthur Caplan, professor of Medical Ethics at New York University Langone Medical Center, joins the show to explain how these genetic tests work, and how you might be able to predict cancer by looking at your DNA.